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Abstract
Obesity as a global epidemic has rapidly increased in incidence in the recent few decades 
and represents one of the biggest public health challenges. Obesity plays a major risk for 
various diseases such as cardiovascular disease (CVD), diabetes mellitus (DM), hyper-
cholesterolemia, osteoarthritis and some form of cancers. Bariatric and metabolic surgery 
provides the best solution for obesity and its associated comorbidities. This chapter will 
discuss in detail the commonly performed bariatric and metabolic surgeries.
Keywords: bariatric surgery, metabolic surgery, Roux-en-Y gastric bypass, sleeve 
gastrectomy, duodenojejunal bypass, proximal jejunal bypass, obesity, type 2 diabetes
1. Introduction
Bariatric surgery has been established to be the most effective treatment for morbid obesity, 
producing sustained and durable weight loss with improvement or remission of comorbidi-
ties and longer life [1]. The procedures undertaken to treat morbid obesity have changed over 
a period of time and recently newer procedures are being developed with lesser morbidity 
and mortality and better results. The resolution of comorbidities such as type 2 diabetes mel-
litus (T2DM), hypertension and others after bariatric surgery gave impetus to the concept of 
metabolic surgery. Metabolic surgery has become increasingly effective and accepted option 
for patients with T2DM [2]. This chapter will describe in detail two most commonly per-
formed procedures, laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gas-
tric bypass (LRYGB). Part of the chapter also details the sleeve gastrectomy-based procedures 
which include sleeve gastrectomy with loop duodenojejunal bypass (LDJB-SG) and sleeve 
gastrectomy with proximal jejunal bypass (SG-PJB).
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2. Laparoscopic sleeve gastrectomy
Laparoscopic Sleeve Gastrectomy (LSG) or “sleeve” is now one of the most commonly per-
formed bariatric procedures worldwide. It is a purely restrictive procedure without intestinal 
bypass. In 1999, Michel Gagner and his team performed the first laparoscopic duodenal switch 
on the porcine model and found it to be feasible. Laparoscopic duodenal switch was later per-
formed in morbid obese patients and found to have higher morbidity in higher BMI patients. 
Staged procedure was then undertaken to reduce the mortality and morbidity with laparo-
scopic sleeve gastrectomy as the first stage of a two-stage duodenal switch. However, the initial 
weight loss after LSG alone was found to be adequate and maintained over a period of time. 
The second stage of surgery was deferred or was not required at all and patients maintained 
good weight loss with just the first stage. After this success and some modifications to the 
procedure, sleeve gastrectomy was established as an effective stand-alone bariatric procedure.
Apart from restriction of size of stomach, reduction in the “hunger hormone” ghrelin, after 
LSG decreases appetite. Advantages of LSG include lower operative complexity, relative 
safety and maintenance of pylorus and easy convertibility to other procedures. Also, since 
there are no bowel bypass problems of internal herniation, small bowel obstruction, micronu-
trient deficiencies and malnutrition will not be encountered.
The disadvantages of the procedure include irreversibility, possibility of staple line leak, 
bleeding and stricture of gastric tube. The incidence of gastroesophageal reflux has also been 
found to be increased in some patients undergoing this procedure.
2.1. Indications and contraindications
Indications for this procedure include BMI ≥ 40 kg/m2 without comorbidities or ≥35 kg/m2 with 
comorbidities. This can also be offered as a first stage of biliopancreatic diversion in patients 
with BMI > 50 kg/m2. Contraindications include chronic alcoholism, drug and substance abuse, 
major psychiatric disorder, severe gastroesophageal reflux disease and chronic duodenal ulcer.
2.2. Preoperative work up and preparation
Comprehensive preoperative workup for sleeve gastrectomy is the same as that of the other 
bariatric procedures. Patients are admitted the day prior to the procedure when they are 
started on clear liquid diet. Single dose of prophylactic antibiotic and proton pump inhibitor 
are given an hour prior to surgery. Low molecular-weight heparin (LMWH) is prescribed to 
lower the incidence of deep vein thrombosis (DVT) and other thromboembolic events, till the 
patient is ambulated.
2.3. Operative technique
2.3.1. Positioning
Patient is positioned flat on the operating table with both upper extremities extended out. 
Patient is secured at the chest and thighs using straps and a foot board in preparation for a 
steep reverse Trendelenburg position. The surgeon and the scrub nurse both stand on the 
patient’s right while the first assistant and the cameraman stand on the patient’s left.
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2.3.2. Port placement
A three-four ports technique is utilized for this procedure as shown in Figure 1. Pneumo-
peritoneum is created by Veress needle or optical trocar is used at the first port. The first 
port is about three finger breadths to the left of umbilicus, at about 20 cm from the xiphi-
sternum. The second 15 mm port is inserted at supraumbilical site. Another 5 mm trocar 
is inserted in the right midclavicular line below the costal margin, for surgeon’s left hand, 
such that the falciform ligament does not cause difficulty in dissection of the hiatus. Lastly 
an optional 5 mm assistant port can be placed in the left anterior axillary line just below the 
costal margin.
2.3.3. Placement of liver suspension tape
To elevate the central and left lobe of the liver, a liver suspension tape (LST) was designed. 
Two pieces of Jackson-Pratt (JP) drain measuring 2 cm each were cut and fixed with 2/0 poly-
propylene suture (Ethicon W8400 2-0 Prolene blue 70 mm round bodied). The lateral segment 
of the left lobe was suspended using the tape by passing the needle through the liver, out 
through the anterior abdominal wall and secured with clamps. Another LST was inserted in 
the medial aspect of left lobe of liver to retract the liver completely.
The LSTs should not be placed more than 2 cm away from the liver edge to achieve optimal 
retraction and prevent major bile duct or vessel injury (Figure 2). Alternatively, a Nathanson 
Figure 1. Port placement for LSG.
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liver retractor (C-NLRS-1001 Cook Medical) may be used in order to achieve good exposure 
of the entire length of the stomach and duodenum. This may be placed using a 5 mm port 
inserted in the subxiphoid area.
2.3.4. Mobilization of the gastrocolic ligament
Dissection of the gastrocolic ligament close to the greater curvature of the stomach com-
mences at a point opposite the incisura angularis. A window in the lesser sac is created and 
dissection is started using a vessel sealing energy device (Ligasure™ vessel sealing device by 
Covidien-Medtronic or Harmonic Ace by Ethicon). By staying very close to the gastric wall, 
the entire gastrocolic ligament is detached up to the angle of His taking care at the area of the 
short gastric vessels at the splenic hilum (Figures 3 and 4). Care should be taken not to injure 
left gastric vessels.
2.3.5. Dissection at the angle of His
Fundus of the stomach must be mobilized from its adhesions and completely resected. A 
very useful anatomical landmark is to expose the left crus of the hiatus. Dissection of the left 
crus is terminated once the left phrenoesophageal ligament has been completely visualized 
(Figure 5). The posterior attachments of the fundus to the anterior border of the pancreas are 
completely mobilized to properly identify and preserve the left gastric vessels (Figure 6).
The anterior portion of the gastroesophageal fat pad (Belsey’s pad of fat) is then dissected in 
order to expose half of the anterior portion of the GE junction. Care is taken not to completely 
devascularize this fat pad which may increase the rate of leak at the GE junction.
Figure 2. Retraction of left lobe of liver with liver suspension tape.
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2.3.6. Dissection of the caudal part of the gastrocolic ligament
The gastrocolic ligament at the area of the right gastroepiploic vessel is dissected caudally till 
the distance of 4 cm from the pylorus. Dense adhesions around the prepyloric area may be 
encountered and should be taken down individually (Figure 7).
Figure 3. Start of dissection by creating a window in the lesser sac.
Figure 4. Dissection of the gastrocolic ligament at short gastric vessels near splenic hilum.
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2.3.7. Sleeve gastrectomy
Prior to the creation of the actual sleeve, make sure that the entire stomach is laid down flat. 
At this point, the anesthesiologist inserts an orogastric tube with its tip positioned by the sur-
geon under direct visual guidance. Using an L-hook dissector (STORZ 37370DL Monopolar 
Dissecting L-Hook Cannula), marking on the anterior surface of the stomach is done which 
Figure 5. Dissection at the angle of His exposing the left crus and phrenoesophageal ligament.
Figure 6. Complete mobilization of the posterior attachments of the fundus and anterior border of the pancreas.
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will serve as a guide for the surgeon to place the endostapler with 38 Fr orogastric tube as stent 
(Figure 8). For the first staple firing, the stapling device is placed 4 cm away from the pylo-
rus and 2.5–3 cm away from the incisura angularis in order to prevent narrowing (Figure 9). 
A black 60 mm reload (EGIA60AXT Endo GIA 60 mm articulating extra-thick reload with 
Tri-Staple Technology) or a green 60 mm green reload (ECR60G Echelon Endopath stapler 
reload cartridges by Ethicon) using manual or powered device is used. Successive firings 
Figure 7. Dissection of the gastrocolic ligament toward the pylorus.
Figure 8. Marking of the transection line along the anterior surface of the stomach.
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of the stapling device toward the gastric fundus are done using either a 60 mm purple car-
tridge (EGIA60AMT Endo GIA 60 mm articulating medium/thick reload with Tri-Staple 
Technology) or a 60 mm blue cartridge (ETHECR60B Echelon Endopath stapler reload car-
tridges by Ethicon) (Figure 10). Commencing after placement of the second stapler, loose 
migratory crotch staples must be removed in order to prevent improper formation of the 
Figure 9. First staple firing 4 cm from pylorus and 2.5–3 cm away from the incisura.
Figure 10. Successive firings of the staple device toward the fundus.
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suture line (Figure 11). Constant communication with the anesthesiologist is of paramount 
importance, inserting and withdrawing the orogastric tube before and after application of 
each stapler to make sure the bougie is not stapled into the remnant stomach. It is also highly 
recommended to check the posterior aspect of the stomach before each firing of the device in 
order to avoid twisting and in-folding of tissues. The entire fundus, including its posterior 
Figure 11. Removal of migratory crotch staples.
Figure 12. Staple firing 1 cm away from the GE junction.
Bariatric and Metabolic Surgery
http://dx.doi.org/10.5772/107288
35
wall, is to be included in the resected part. Before firing of the last stapler, always verify that 
the stapler is placed not less than 1 cm from the GE junction and that both tips of the stapler 
are always in sight (Figure 12).
2.3.8. Hemostasis
The entire length of the staple line should be inspected for any bleeding. Bleeding may be controlled 
using electrocautery, clips or over sewing. No buttressing material is placed over the staple line.
2.3.9. Fixing the tube
One or two fixing stitches are taken between the stapled sleeve and the retroperitoneal fat to 
prevent rotation of the sleeve tube.
2.3.10. Specimen extraction
The LSTs are removed and the entry and exit points on the liver are cauterized to achieve 
hemostasis. Specimen is then extracted through the umbilical port and closure of the rectus 
sheath done with 2-0 Vicryl. Subcutaneous layers of all ports closed with 3-0 Vicryl and skin 
closed with interrupted subcuticular stitches. Dermabond is applied and dressing done.
2.3.11. Surgical outcomes
The mechanism of action of LSG appears to be by the restriction of the volume of stomach 
and the removal of ghrelin-producing fundus [3]. The decreased ghrelin leads to early satiety 
and decreased hunger. Another mechanism is increased gastric emptying which combined 
with decreased gastric acid secretion causes incomplete digestion [4]. Increased gastric emp-
tying is associated with higher levels of glucagon-like-peptide-1 (GLP-1), a glucose-regulating 
insulin-enhancing agent, which has been linked to weight loss and resolution of type 2 dia-
betes mellitus [5].
In a retrospective study, the EWL after 3 and 6 years follow-up of LSG was 72.8 and 57.3%, 
respectively [4]. Gustavo et al. in their long-term study showed a mean %EBMIL (percentage 
of excess BMI Loss) of 82.4, 75.9 and 62.5 and % TWL (percentage of total weight loss) of 28.5, 
25.8 and 21 at 3, 6 and 11+ years of follow-up, respectively [6].
3. Sleeve-based procedures
One of the arguments against LSG is that its weight loss as well as its efficacy in diabetes 
remission is inferior and not sustainable compared to RYGB. This is owed to the fact that 
LSG do not own the content of bowel bypass. Laparoscopic loop duodenojejunal bypass with 
sleeve gastrectomy (LDJB-SG) and sleeve gastrectomy with proximal jejunal bypass (SG-PJB) 
are a combination of both a restrictive and malabsorptive procedures (Figure 13 and 28). First 
described by Huang et al. in 2011, LDJB-SG has a lower incidence of dumping syndrome and 
marginal ulcer, both commonly experienced in RYGB, due to an intact pylorus which acts as 
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a sphincter mechanism and a creates a neutral condition from mixture of gastric acid, pancre-
atic juice and bile around the duodenojejunal anastomosis [7]. SG-PJB was designed by Alamo 
et al. in 2005 and later revised in 2009 [9, 10]. Surgical results of weight loss and comorbidity 
resolution were comparable to Roux-en-Y gastric bypass in his reports. Both LDJB-SG and 
SGPJB can be an alternative operation that could potentially lessen the complications associ-
ated with the conventional gastric bypass.
3.1. Loop DuodenoJejunal Bypass with Sleeve Gastrectomy
3.1.1. Indications and Contraindications
Indication for this procedure includes BMI ≥ 40 kg/m2 without comorbidities or ≥35 kg/m2. 
This can also be offered as a surgical treatment for poorly controlled type 2 diabetes in Asian 
patients with BMI ≥ 32.5 kg/m2 without comorbidities or >27.5 kg/m2 with comorbidities. 
Contraindications include chronic alcoholism, drug and substance abuse, major psychiatric 
disorder, severe gastroesophageal reflux disease and chronic duodenal ulcer [8].
3.1.2. Preoperative work up and preparation
Comprehensive preoperative workup for DJB-SG is the same as that of the other bariatric 
procedures. Patients are admitted the day prior to the procedure were they are started on 
clear liquid diet. Single dose of prophylactic antibiotic and proton pump inhibitor are given 
Figure 13. Schematic diagram of LDJB-SG.
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an hour prior to surgery. Low molecular-weight heparin (LMWH) is prescribed to lower the 
incidence of deep vein thrombosis (DVT) and other thromboembolic events.
3.1.3. Positioning
Patient is positioned flat on the operating table with both upper extremities extended out. 
Patient is secured at the chest and thighs using straps and a foot board in preparation for a 
steep reverse Trendelenburg position. The surgeon and the scrub nurse both stand on the 
patient’s right while the first assistant and the cameraman stand on the patient’s left.
3.1.4. Operative Technique
3.1.4.1. Port placement
Five-port technique is utilized for this procedure as shown in Figure 14. A 12 mm optical port 
on the left of umbilicus is placed after abdominal cavity is entered using the closed Veress 
technique or via an optical trocar. One 15 mm port is placed in immediate supraumbilical 
region and another 12 mm port is placed to the right of umbilicus mirroring the one on the left, 
both of which serve as the surgeon’s right hand working ports. A 5 mm trocar is placed in the 
right midclavicular line below the costal margin for the surgeon’s left hand while another 5 
mm trocar is placed in the midclavicular line below the left subcostal margin for the assistant.
Figure 14. Port placement for LDJB-SG.
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3.1.4.2. Placement of liver suspension tape
An LST previously discussed earlier in this chapter is utilized. However, instead of using a 
2.5 cm cut JP drain, 5 cm is used for the second tape in order to lift both the lobes of the liver 
along with the falciform ligament away from the field (Figure 15).
3.1.4.3. Sleeve gastrectomy
The formation of the gastric sleeve tube is done in a similar way as described earlier in this 
chapter.
3.1.4.4. Duodenal transection
Proper exposure of the entire length of the stomach and first part of the duodenum is 
critical to the success of this procedure. After sleeve gastrectomy has been performed, the 
next step is to dissect the first part of the duodenum. A counter traction suture is placed at 
the distal end of the sleeved stomach to visualize the first part of the duodenum (Figure 
16). At a distance approximately 2 cm distal to the pylorus, a tunnel is created posterior 
to the duodenal wall and just anterior to the gastroduodenal artery using a combina-
tion of a blunt dissector and Flexlap Gold Finger retractor (Flexlap Gold Finger Retractor 
by Ethicon Endo Surgery, USA) as seen in Figures 17 and 18. A tape is then passed in 
the tunnel behind the duodenum and lifted laterally and downwards to serve as a trac-
tion while inserting the endostapler (Figure 19). Using a 45 mm curved tip articulating 
tan reload (EGIA45CTAVM Endo GIA 45 mm Curved Tip articulating vascular/medium 
reload with Tri-Staple™ Technology), the first part of the duodenum is transected. Care 
is taken to avoid injury to the common bile duct (CBD), pancreas and major vessels in the 
area (Figure 20) [8].
Figure 15. Liver suspension for both lobes.
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3.1.4.5. Duodenojejunostomy
The ligament of Treitz is identified as it exits at the root of the transverse mesocolon. A length 
of jejunum is measured for 200–300 cm starting from the ligament of Treitz. The loop of jeju-
num is pulled up and a stay suture is placed between the loop of jejunum and pylorus. An 
 enterotomy of 1.5 cm is placed obliquely in the first part of the duodenum and antimesenteric 
Figure 17. Retroduodenal tunnel.
Figure 16. Counter traction suture.
Laparoscopic Surgery40
side of jejunum (Figure 21 and 22). A completely hand-sewn side to side duodenojejunal 
anastomosis in a running fashion is created using a 3-0 absorbable glyconate monofilament 
suture (3-0 B | BRAUN MONOSYN™ UNDYED 28" HR26 TAPER) (Figures 23–25). Then an 
antitorsion suture between antrum and jejunum is placed, around 4 cm proximal to the D-J 
anastomosis [8].
Figure 18. Retroduodenal tunnel passing through the lesser sac using the Goldfinger retractor.
Figure 19. Lifting and retraction of the 1st portion of the duodenum using a tape.
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3.1.4.6. Closure of mesenteric defect
Peterson’s mesenteric defect is closed in a continuous running technique using 2-0 nonabsorbable 
polyester suture (W6977 Ethibond Excel™ Polyester suture) (Figure 26). A Jackson Pratt drain 
is placed under the entire length of stomach tube and duodenojejunal anastomosis (Figure 27).
Figure 20. Duodenal transection.
Figure 21. Stay suture between sleeved stomach and jejunum.
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3.1.4.7. Postoperative care and follow-up
Adhering to the early recovery after surgery (ERAS) postoperative protocol, adequate pain 
control is administered via the intravenous route and early ambulation is encouraged in 
our patients as early as six hours after surgery in order to avoid pulmonary complications. 
Figure 22. Duodenal enterotomy placed obliquely.
Figure 23. Completely hand-sewn duodenojejunal bypass.
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Once the patient is fully awake, clear liquid diet as instructed by our dietitian is commenced. 
Intravenous antibiotic is administered for one more day. Patients are usually discharged 2–3 
days after surgery. Patients are placed on bariatric diet as instructed by the dietitian. Proton 
pump inhibitors are given for 1 month after surgery. Follow-up schedule is as follows: 1 week, 
1, 3, 6 and 12 months after surgery. One year after the surgery, patients are advised to follow-
up every 6 months thereafter.
Figure 24. Anterior wall of DJB.
Figure 25. Posterior wall of DJB.
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3.1.5. Surgical Outcomes
The mechanism of weight loss in LDJB-SG is due to the resection of Ghrelin-secreting cells 
located in the fundus of the stomach. A significant drop in this hormone’s level after the pro-
cedure causes decrease in sensation of hunger and early satiety. Furthermore, aside from its 
weight-loss effect, caloric restriction also helps in the improvement of insulin resistance and 
Figure 26. Closure of Petersons defect.
Figure 27. Placement of JP drain along DJB anastomosis and entire length of the sleeve suture line.
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increase in glucose tolerance. However, the efficient glycemic control of this procedure is pre-
dominantly due to the exclusion of the duodenum (Foregut theory) and the faster delivery of 
undigested food and more concentrated bile to the distal small bowel (Hindgut theory) which 
ensures secretion of incretins.
In a prospective study by Huang et al. published in 2013 comparing LDJB-SG with RYGB, 
LDJB-SG had a superior remission rate of T2DM (60% vs 49%) and a better over-all gly-
cemic control (90% vs 71%) compared to RYGB in patients with BMI ≤ 35 kg/m2 at 1 year 
after surgery. Fasting blood sugar levels was also significantly lower in the LDJB-SG group 
(98.0 ± 18.0 vs 106.0 ± 31.7 mg/dl). The drop in HbA1C was also lower in the LDJB-SG com-
pared to the RYGB (6.0 ± 0.9 vs 6.3 ± 1.2) although this did not attain a statistically significant 
level (P value = 0.442). Resolution of other obesity-related comorbid factors were also seen 
in LDJB-SG that was comparable to the RYGB group (Hypertension = 85.7% vs 88.2% and 
Dyslipidemia = 70% vs 76.6% resolution rates) [8].
In a case-matched study comparing of 30 patients undergoing LDJB-SG and 30 patients under-
going RYGB, the mean BMIs dropped significantly to 22.4 kg/m2 (±2.4) (range 18.4–27 kg/m2) 
and 21.9 kg/m2 (±2.5) (range 17.7–26.5 kg/m2) from preoperative values of 28.2 kg/m2 (±3.6) and 
27.8 kg/m2 (±3.8) at 1 year after surgery (p < 0.01). However, no statistical difference was seen 
between the two groups. HbA1c and fasting glucose were also significantly decreased 1 year 
after surgery compared to its preoperative value from 8.98 (±1.75%) to 6.52% (±1.03) and 168.3 
(±54.9 mg/dL) to 106.5 mg/dL (±28.2 mg/dL). Comparing complete remission of T2DM in 1 
year after surgery, the LDJB-SG had a remission rate of 36.6% of patients (11/30) compared to 
30% (9/30) in the RYGB group. As far as complications, the rate for early complication favors 
that of RYGB (1 case vs 4 cases). However, there is a note of a trend toward lower occurrence 
of late complication rate in LDJB-SG compared to RYGB (5 vs 8 cases, p < 0.08) [11].
Lee et al. compared single anastomosis duodenojejunal bypass with sleeve gastrectomy 
(SADJB-SG) with RYGB and minigastric bypass (MGB). The operation time was signifi-
cantly longer in SADJB-SG compared to the other types of bypass (181.7 mins vs 160 mins 
for RYGB vs 120.1 mins for MGB; p < 0.01). During the interim follow up period at 1, 3, 6 
and 12 months after surgery, the mean BMI dropped to 32.9 ± 4.8, 29.9 ± 6.8, 27.6 ± 5.4 and 
25.9 ± 4.6 kg/m2, respectively. The percentage weight loss during these same follow-up 
periods were 15.1, 20.3 25 and 32.7%. 12 months after surgery, comparing percent weight 
loss (% WL) of the three procedures, the results showed a higher percent weight loss for 
SADJB-SG (32.7 ± 7.9% SADJB-SG vs 28.9 ± 9.0% MGB vs 26.1 ± 4.1% RYGB). Results also 
showed a superior percent excess weight loss for SADJB-SG (80.3 ± 24.8%) compared to 
the two bypass procedures (68.6 ± 58.2% MGB and 63.4 ± 31.8% RYGB). In the same report, 
T2DM was seen in > 80% of the subjects with a preoperative mean HbA1c level of 9.2%. This 
value decreased to 6.1% 1 year after surgery with a complete remission rate of T2DM in 64% 
of the patients [12].
In an attempt to evaluate the role of duodenal exclusion in glycemic control, a matched 
group study comparing LDJB-SG and SG alone was done. At 1 year after surgery, the 
LDJB-SG (26 patients) presented with a higher percent excess weight loss (87.2 ± 14.9% vs 
67 ± 27.0%; p = 0.23) and a lower BMI (23.9 ± 2.2 vs 26.1 ± 3.7; p = 0.065) compared to the SG 
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alone group (29 patients). As far as T2DM remission rate is concerned, the LDJB-SG had 
a 92.3% total glycemic control rate compared to 86.2% in the SG alone group. The mean 
reduction in the HbA1c level for the LDJB-SG was likewise higher compared to the SG 
group (2.8 vs 2.1% p = 0.45) [13].
3.2. Sleeve gastrectomy with proximal jejunal bypass (Figure 28)
3.2.1. Indication and contraindication
The indications and contraindications of PJB-SG are the same as that of the conventional 
stand-alone sleeve gastrectomy. Furthermore, this can also be offered as a metabolic surgery 
for patients with BMI between 27.5 and 35 with type 2 Diabets.
3.2.2. Preoperative workup and preparation
Like in all bariatric procedures, a complete preoperative workup should be done in order to 
select appropriate candidates for the procedure. All patients are evaluated by a multidisciplinary 
Figure 28. Schematic diagram of LPJB-SG.
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team dedicated in bariatric surgery including a bariatric surgeon, bariatric physician, gastroen-
terologist, anesthesiologist, psychiatrist, nutritionist and fitness coach. Other specialists may be 
called upon if required.
3.2.3. Positioning
Patient is positioned supine with upper extremities abducted and lower extremities adducted. 
Patient is then secured to the operating table using straps and foot boards. Patient is placed in 
steep reverse Trendelenburg position.
3.2.4. Operative technique
3.2.4.1. Port placement
A 4-port technique is utilized with the surgeon positioned on the patient’s right side and the 
assistant and camera man standing on the patient’s left. Port placement is similar to LSG with 
an assistant port in left anterior axillary line below the costal margin (Figure 29).
3.2.4.2. Pneumoperitoneum
Pneumoperitoneum is accomplished either via Veress technique or through a 12 mm optical 
trocar using a 30-degree scope in the left periumbilical area.
3.2.4.3. Placement of liver suspension tape
Liver retraction is done using the LST similarly placed as in the standard LSG technique. 
Alternatively, a Nathanson liver retractor can also be used.
3.2.4.4. Sleeve gastrectomy
Standard sleeve gastrectomy is performed as previously described earlier in this chapter.
3.2.4.5. Proximal jejunal bypass
After completing the sleeve gastrectomy, ligament of Treitz is identified. Transection of the 
jejunum is done at 20 cm from the ligament of Treitz using either a 45 mm white cartridge 
reload (EGIA45AMT Endo GIA™ 45 mm articulating medium/thick reload with Tri-Staple 
Technology) or a 45 mm white cartridge reload (ECR45W Echelon Endopath™ tri-stapler 
reload cartridges by Ethicon). Next 300 cm of small bowel is measured distally and a side-
to-side jejunojejunal anastomosis was fashioned out using the same cartridge and stapling 
device. The jejunojejunostomy is created with hand-sewn technique using 3-0 Absorbable 
Glyconate Monofilament running suture (3-0 B | BRAUN MONOSYN™ UNDYED 28" HR26 
TAPER) (Figures 30–32).
3.2.4.6. Closure of mesenteric defect
The mesenteric defect is closed with simple running sutures using 2-0 nonabsorbable polyes-
ter suture (Ethibond Excel™ polyester suture). No drain is placed.
Laparoscopic Surgery
Figure 29. LPJB-SG port placement.
Figure 30. Transection of Bilio-pancreatic limb 20 cm from ligament of Treitz.
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3.2.4.7. Gastric sleeve fixation
The suture line of the sleeved stomach is anchored with one or two stitches at the retroperito-
neal fat using 3-0 Polyglactin 910 multifilament absorbable suture (J774D Ethicon 3-0 Coated 
Vicryl™ Taper SH). This prevents inadvertent twisting of the tubularized stomach (Figure 33).
Figure 32. Closure of jejunojejunal anastomosis.
Figure 31. 300 cm bypassed proximal jejunum.
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3.2.5. Surgical Outcomes
Factors that contribute to the magnitude of weight loss and diabetic remission in sleeve-based 
procedures are still not fully elucidated. It probably owes its weight loss capabilities by elimi-
nating the function of the stomach as a reservoir hereby reducing caloric content of processed 
food. Furthermore, because of the jejunojejunal bypass, the terminal ileum is exposed much 
earlier to undigested food and a more concentrated bile, both of which stimulate the release 
of incretins, primarily glucagon-like peptide 1 (GLP-1).
In the original study of Alamo et al., the average BMI and average weight at 12 months after 
vertical isolated gastroplasty with gastroenteral bypass were 23.4 ± 3.3 kg/m2 (19.2–27.7) and 
65.1 ± 15 kg (46–83) from 41.2 ± 5.1 kg/m2 (35.3–57.8) and 110.7 ± 16.2 kg. The mean percent 
excess weight loss (% EWL) was 90.2 ± 11.9% [3]. In other studies, the mean BMI was reduced 
to 21.4 ± 1.9 kg/m2 at 18 months’ follow-up from 31.6 ± 2.1 kg/m2 with a mean percent EWL of 
75.7 ± 8.5%. Comparing these figures with RYGB, in the study by Higa et al., where patients 
were followed-up for 10 years, the mean percent excess weight loss was 57% and the average 
postoperative BMI was 33 ± 8.0 kg/m2 at 10 years [14].
In a cohort study of 49 patients (2012) evaluating the efficacy of SGPJB in ameliorating 
T2DM in patients with BMI < 35 kg/m2, 81.6% (40/48) of patients with T2DM achieved 
 complete remission after SGPJB with the remaining nine patients achieving improvement. 
As far as discontinuation of oral hyperglycemic agents and insulin dependence are con-
cerned, 97.6% (40/41) of patients stopped taking their medications and 100% (8/8) stopped 
using insulin [10].
Figure 33. Anti torsion stitch.
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4. Laparoscopic Roux-En-Y Gastric Bypass (Figure 34)
Mason observed that distal gastrectomy with Billroth II reconstruction causes weight loss. 
The first open RYGB was performed for weight loss in 1967 while the first Laparoscopic RYGB 
was performed by Wittgrove [15]. Since then, laparoscopic RYGB is one of the most com-
monly performed bariatric procedure done for excess weight loss (Figure 34).
Based on the 1991 NIH criteria, there are a number of widely accepted indication and contra-
indication which make a patient suitable for Bariatric or weight loss surgery:
• BMI > 40 without comorbidities.
• >35 with associated obesity-related illness such as diabetes or sleep apnea.
• Failed reasonable attempts at other weight loss techniques.
Figure 34. Schematic diagram of LRYGB.
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• Obesity-related health problems.
• No psychiatric or drug dependency problems.
• A capacity to understand the risks and commitment associated with surgery.
• Pregnancy not anticipated in the first 2 years following surgery.
For Asians, BMI is reduced by 2.5 for the above.
4.1. Operative technique
4.1.1. General preparations
Preoperative investigation includes standard basic blood profile, thyroid function test, 
serum cortisol level, HbA1c and C-peptide if diabetic, whole abdominal ultrasound and 
upper gastrointestinal endoscopy. Patient will be placed on NPO and started with intrave-
nous drip 125–150 ml/h. Anticoagulants are usually not needed but thromboelastic stockings 
are applied.
4.1.2. Patient positioning
Patient is positioned supine with both arms stretched out. Surgeon will be on the right side 
of the patient while the assistant surgeon and camera holder will be on the left. The assisting 
nurse will stand on the same side as the surgeon. Monitor(s) are placed at the head end of 
patient.
4.1.3. Port placement
A 12 mm optical port placed 3-finger breadth left lateral to umbilicus. A 5 mm port is placed 
4-finger breadth to the right of umbilicus for surgeons left hand working port. A 12 mm port 
is placed at 45 degrees to right hand port in the right mid clavicular line for surgeon’s left 
hand and stapler insertion. Another 5 mm port is inserted in upper left subcostal region in the 
anterior axillary line for assistant surgeon (Figure 35).
4.1.4. Liver suspension tape
Liver retraction is done with liver suspension tape using a straight needle prolene suture-
Jackson Pratt drain as previously described in this chapter for LSG.
4.1.5. Creation of gastric pouch
Gastric pouch is created by marking with orogastric calibration tube (OGCT) balloon with 
25 ml insufflation. Perigastric dissection is done with hook diathermy at lesser curve with 
preservation of hepatic branch of vagus nerve, usually after the first vascular branch. Two-
three staplers (medium thickness) are used to create the gastric pouch. The final pouch size 
would be about 15–20 ml. Adhesion on the posterior aspect of gastric pouch are cleared. A 
small gastrostomy is created at the posterior side of the pouch with hook diathermy for the 
creation of gastrojejunostomy (Figures 36–42).
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4.1.6. Gastrojejunostomy
Ligament of Treitz is identified and 100 cm of proximal jejunum is measured. Jejunotomy 
is created with hook cautery and loop of jejunum is anastomosed to the gastric pouch with 
linear stapler. Diameter of the gastrojejunal stoma is about 1.5–2 cm. Jejunum is discon-
nected just proximal to gastrojejunostomy with a 45 mm white cartridge reload (EGIA45AMT 
Endo GIA™ 45 mm articulating thin reload with Tri-Staple Technology or ECR45W Echelon 
Endopath™ tri-stapler reload cartridges by Ethicon) to avoid creating a “candy cane” blind 
loop. Closure of gastrojejunal enterotomy is performed with Monocryl 3-0. 38 Fr orogastric 
tube is passed through the gastrojejunal anastomosis to check for patency (Figures 43–46).
4.1.7. Jejunojejunostomy
Jejunum is measured for a distance of 100 cm from gastrojejunostomy and side to side jejunoje-
junostomy is created with 45 mm cartridge (EGIA45AMT Endo GIA™ 45 mm articulating thin 
reload with Tri-Staple Technology or ECR45W Echelon Endopath™ tri-stapler reload cartridges 
by Ethicon). Closure of jejunojejunal enterotomy is done with 3-0 Monocryl (Figures 47 and 48).
Figure 35. Port placement.
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Figure 36. Calibration of gastric pouch.
Figure 37. Perigastric dissection.
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Figure 38. Firing of first staple.
Figure 40. Firing of the 2nd stapler toward the angle of His.
Figure 39. Dissection of adhesions at posterior gastric pouch.
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Figure 41. Firing of last stapler 1 cm away from GE junction.
Figure 42. Creation of 1.5–2 cm gastrotomy.
Figure 43. BP limb measuring 100–250 cm from the ligament of Treitz.
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Figure 44. 1.5–2 cm side to side gastrojejunostomy.
Figure 45. Transection of jejunum proximal to GJ anastomosis with thin stapler as close to GJ anastomosis as possible to 
avoid creating a candy cane stick blind loop.
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Figure 46. Gastrojejunal anastomosis completed by closure with single layer continuous suture using MONOSYN 3-0 
round body needle.
Figure 47. Side to side jejunojejunostomy.
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4.1.8. Closure of mesenteric defects
Closure of mesenteric defects is performed with nonabsorbable sutures at jejunojejunal mes-
entery and Peterson defect (jejunotransverse mesocolon) to prevent internal herniation.
4.1.9. Removal of liver suspension, hemostasis, deflation and closure
After ensuring hemostasis at staple lines and anastomosis, liver suspension tapes are removed 
and hemostasis of liver punctures is done with diathermy.
4.2. Surgical outcome
4.2.1. Excess weight loss
Weight loss after bariatric surgery is dramatically seen in the first 12 months after surgery 
and continues at a slower rate up to 18 months postoperation. Excess weight loss after gastric 
bypass is between 72 and 82% within 12 months after surgery [16–18].
4.2.2. Improvement of comorbidities
Gastric bypass resulted in marked improvement in the biochemical markers of diabetes. Type 2 
Diabetes Mellitus resolution is as high as 90.9% with mean fasting glucose reduction from 204 to 
103 mg/dl, mean HbA1c reduction from 9.2 to 5.9% without T2DM medication in 12 months follow 
up. Up to 90% of patient did not need medication for control of glycaemia post operatively [19].
Figure 48. Hand-sewn closure of jejunojejunal anastomosis completed with single layer continuous suture using 
MONOSYN 3-0 round body needle.
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Gastric bypass can achieve a dramatic improvement of nonalcoholic fatty liver disease 
(NAFLD) both biochemically and histologically in morbid obesity [20]. Likewise, with signifi-
cant weight loss and reduction of BMI after gastric bypass, pulmonary function improved in 
obese patients, which are correlated with decrease in waist circumference and possibly intra-
abdominal pressure [21].
4.2.3. Complications
Complications occur in up to 20% patients and include anastomotic leak (0.25%), acute and 
late gastrojejuntostomy stricture (5%), gastrojejunostomy hemorrhage (1.5%), acute and late 
jejunojejunostomy stricture (1.5%), iron deficiency anemia, marginal ulcers hemorrhage 
(1.5%), gastric pouch dilatation (1.5%), nonspecific abdominal pain, hair loss, internal hernia-
tion if mesenteric defects are not closed and rarely peroneal nerve palsy, acute cholecystitis, 
biliary stone with obstruction and cholangitis and intra-abdominal abscess [16–18].
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